Company research / BLTE

BELITE BIO, INC (BLTE)

Build a valuation ↗↓ Download CSV

CIK 0001889109

Key ratios (year ended 2025-12-31)

-10.1%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-08-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Operating Income	-$84.21M	-$40.00M	-$31.67M	-$12.82M	-$9.80M	-$5.74M	—
Net Income	-$77.61M	-$36.14M	-$31.63M	-$12.65M	-$9.67M	-$5.75M	—
EPS (Diluted)	$-2.31	$-1.18	$-1.19	$-0.63	$-1.01	$-0.65	—
Total Assets	$780.56M	$152.13M	$94.64M	$44.27M	$18.35M	—	—
Total Liabilities	$10.07M	$6.31M	$4.21M	$2.77M	$1.64M	—	—
Shareholders' Equity	$770.49M	$145.82M	$90.43M	$41.50M	-$15.09M	-$7.04M	-$3.74M
Cash & Equivalents	$352.93M	$31.68M	$88.16M	$42.09M	$17.34M	—	—
Operating Cash Flow	-$36.99M	-$29.23M	-$29.84M	-$11.46M	-$7.47M	-$4.44M	—
Capital Expenditures	$71.0K	$116.0K	$63.0K	$394.0K	$74.0K	—	—
Shares Outstanding	39.34M	31.83M	29.15M	24.90M	10.27M	—	—
Weighted Average Diluted Shares	33.54M	30.54M	26.59M	19.98M	9.57M	8.79M	—
EPS (Basic)	$-2.31	$-1.18	$-1.19	$-0.63	$-1.01	$-0.65	—